华泰金融(HK):给予京东健康(06618.HK)“买入”评级 目标价33.00港元
华泰金融(HK)10月16日发布公告。Given mild consumer sentiment, JD Health International’s (JDH) revenue growth acceleration may be slower than we previously expected. We thus trim our 2024/2025/2026 revenue forecasts to RMB57.5/62.2/66.2bn (previous: RMB57.8/ 62.6/66.7bn). Additionally, considering its interest income may fall short of our prior expectations amid rate cuts, we lower our non-IFRS net profit estimates for 2024 /2025/2026 to RMB4.25/4.80/5.22bn (previous: RMB4.43/5.02/5.71bn). We switch to a relative valuation method, and value the stock at 20x 2025E non-IFRS PE, a premium over its peers’average of 14.0x on Visible Alpha consensus, to factor in JDH’s market share gains in the pharmaceutical sector due to its high distribution efficiency. We adjust our target price to HKD33.00 (previous: HKD41.30). BUY.
0人
- 每日推荐
- 股票频道
- 要闻频道
- 港股频道
- 福建莆田率先调整住宅转让个税政策
- 央行、科技部对重点地区做好科技金融服务作出部署
- 川渝行情火爆!房地产板块大幅走强,沪指继续险守3200点
- 10月16日晚间公告集锦:四川双马称公司正在筹划现金收购股权事项
- 优化资源配置 部分公司加速处置资产
- 中证沪港深互联互通中小综合工业指数报2580.50点,前十大权重包含宇通客车等
- AI新动能拉动行业反转后呈逐季加速增长趋势
- 10月16日PA66产业链情报
- 北水成交净卖出15.46亿 内资加仓内房股 抛售盈富基金超47亿港元